Willis-Knighton Surgeons Celebrate 50th Focal One™ Case

Dec 07, 2023

Noninvasive Technology Treats Prostate Cancer

Surgeons at WK Bossier Health Center celebrated a milestone on December 4 – the 50th case using Focal One™ technology to treat prostate cancer. The noninvasive procedure designed for patients with localized prostate cancer was introduced last December at WK Bossier with Gerard Henry, MD, performing the first case last year and the 50th case on Monday. Additional urologists offering the Focal One™ procedure are W. Stewart Bundrick Jr., MD, and Christopher Wilson, MD.

Focal One™ combines real-time ultrasound image guidance with magnetic resonance imaging (MRI) and biopsy data presented in 3D. Using a probe, the doctor navigates to the tumor in real time, directs high speed ultrasound energy at the targeted area and ablates only the diseased portion of the prostate. No incisions are made.

“For low volume, low grade prostate cancer, Focal One™ is a very safe treatment choice,” said Dr. Henry.

The procedure appeals to patients because it minimizes the effects of urinary incontinence and erectile dysfunction that are often associated with radical prostatectomy and traditional radiation.

Focal One™ is one of the numerous advanced services available for patients with prostate cancer at various stages of their disease. Proton therapy and Pluvicto are also part of the cancer fighting advances at Willis-Knighton, the only healthcare facility in Louisiana to offer proton therapy.